Gland Pharma Limited (GLAND): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Gland Pharma Limited, explained in plain English.

• ▪Gland Pharma Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪GLAND closed at ₹3,159.00 on 4 November 2026.
• ▪Over the past year the shares are up 65.2%, trading between ₹1,573.60 and ₹3,174.00.
• ▪Reported fundamentals show a net margin of 16.78%, debt to equity of 2.74.
• ▪Our transparent MaxGrade checklist scores it B (71/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 34.1% with a maximum drawdown of -16.48% and a beta of 0.58 against NIFTY 50.

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 4 Nov 2026. Pre-open auction.